Keynote Address!
February 5 | 8:40AM-9:25PM
Session 1: Keynote: Personalized Medicine and the Pharmaceutical Industry
The Keynote has Been Released! Michael Ybarra, MD, Chief Medical Officer, PhRMA
Featured
Want to learn more about Global Pharmacovigilance and Risk Management Strategies Conference? You've come to the right site!
Today’s Baltimore is a place where good ideas and ambition are the currency that matter most. It’s a place where art is seen as a catalyst for conversation, food as a means of connection, and history as an opportunity for education. It’s an essential destination full of inclusive neighborhoods where all visitors will feel invited, welcomed, and seen. Click here to check out all the tour guides based on your interests.
Discover Baltimore!
项目委员会
-
James Buchanan, PharmD President
Covilance LLC, United States -
Mariette Boerstoel-Streefland, MD, MBA, MS Senior Vice President, Worldwide Safety Officer
Bristol-Myers Squibb Company, United States -
Barbara Hendrickson, DrMed, MD Clinical Associate, Pediatric Infectious Diseases
University of Chicago, United States -
Scott Janiczak, PharmD, MPH Safety Evaluator, LCDR, Division of Pharmacovigilance I, OSE, CDER
FDA, United States -
Mamiko Kasho Executive Director, Global PV Management Dept., Global Safety HQs
Eisai Co., Ltd., Japan -
Susan Kindig, JD, MD Prior Executive Director, Medical and Drug Safety
United States -
Mengchun Li, MD, MPA Senior Director, Clinical Research, Infectious Disease
Merck & Co., Inc., United States -
Joseph Paradis, PharmD Associate Director for Medication Error and Risk Management Initiatives, CDER
FDA, United States -
Mark Perrott, PhD Managing Partner
Axian Consulting Ltd., United Kingdom -
Sarah Vaughan Head of Vigilance Operations
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom -
Yijing (Hellen) Zhang, MPharm Executive Director, Global Patient Safety
Beigene, China -
Jeremy Jokinen, PhD, MS Vice President and Head, Safety Evidence and Sciences
Bristol-Myers Squibb Company, United States -
Annette S. Williams, MBA, RPh Vice President, Pharmacovigilance
IQVIA, United States